Evidence map›Paper›PMID 26750379›Full record

ArticleJournal of the International AIDS Society2016

Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.

Marie Suzan-Monti, Nicolas Lorente, Baptiste Demoulin, Fabienne Marcellin, Marie Préau, Rosemary Dray-Spira, France Lert, Bruno Spire, ANRS-VESPA2 Study Group

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. HIV-1 heterosexual transmission and association with sexually transmitted infections in the era of treatment as prevention.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Marie Suzan-MontiINSERM, UMR 912 (SESSTIM), Marseille, France.
Nicolas LorenteINSERM, UMR 912 (SESSTIM), Marseille, France.
Baptiste DemoulinINSERM, UMR 912 (SESSTIM), Marseille, France.
Fabienne MarcellinINSERM, UMR 912 (SESSTIM), Marseille, France.
Marie PréauGroupe de Recherche en Psychologie Sociale, Université Lyon 2, Lyon, France.
Rosemary Dray-SpiraINSERM, UMR_S1136, Pierre Louis Institute of Epidemiology and Public Health, Research Team in Social Epidemiology, Paris, France.
France LertCentre de recherche en épidémiologie et santé des populations, INSERM U1018, Villejuif, France.
Bruno SpireINSERM, UMR 912 (SESSTIM), Marseille, France.
ANRS-VESPA2 Study Group
Inserm · FREconomic & Social Sciences, Health Systems & Medical Informatics · FRInstitut de Recherche pour le Développement · FRObservatoire Régional de la Santé d’Alsace · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople living with HIV (PLHIV) on antiretroviral therapy (ART), with sustained undetectable viral load (sUVL) and no history of sexually transmitted infections for at least six months, are considered to have a low risk of HIV transmission (LRT). We aimed to characterize, in a representative sample of French PLHIV, the sexual behaviour of LRT PLHIV compared with non-LRT PLHIV.

methodsThe cross-sectional ANRS-VESPA2 survey was conducted on adult PLHIV attending French hospitals in 2011. The LRT PLHIV group included participants with sUVL and no sexually transmitted infection for at least 12 months. Socio-behavioural and medical data were collected. Chi-square tests helped compare sexual risk indicators between LRT and non-LRT PLHIV. The survey's retrospective nature allowed us to perform complementary category-based analyses of LRT PLHIV according to whether they had sUVL for at least 18, 24 or 36 months in three socio-epidemiological groups: men who have sex with men (MSM), other men and women.

resultsAnalysis included 2638 PLHIV diagnosed > 12 months with available viral load data. The proportion of LRT PLHIV varied from 58% (≥ 12 months sUVL) to 38% (≥ 36 months sUVL). Irrespective of sUVL duration, we found the following: 1) LRT men (MSM and other men) were more likely to report having no sexual partner than their non-LRT counterparts. Among men having sexual partners in the previous 12 months, no significant difference was seen between LRT and non-LRT men in the number of sexual partners. LRT women were less likely to report having more than one sexual partner than non-LRT women; 2) LRT MSM were more likely to report being in sexually inactive couples than their non-LRT counterparts; 3) among sexually active participants, no difference was observed between LRT and non-LRT PLHIV concerning condom use with their serodiscordant steady partner or with their most recent casual sexual partners.

conclusionsLRT PLHIV with sUVL ≥ 12 months did not report more sexual risk behaviours than their non-LRT counterparts. Because the same result was obtained for those having a sUVL ≥ 36 months, the hypothesis of increased sexual risk behaviour over time in PLHIV meeting non-transmission biomedical criteria is not supported.

Indexed as

Risk-TakingSexual BehaviorAdultAnti-HIV AgentsCross-Sectional StudiesFemaleHIV InfectionsHumansMaleMiddle AgedRetrospective StudiesSexually Transmitted DiseasesAnti-HIV Agentsbiomedical risk of HIV transmissionHIVsexual risk behavioursuccessful ART

Identifiers

PMID26750379
PMCPMC4707296
OpenAlexW2226550830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.